| Literature DB >> 31871419 |
Małgorzata Rumińska1, Ewelina Witkowska-Sędek1, Dorota Artemniak-Wojtowicz1, Maria Krajewska1, Anna Majcher1, Maria Sobol2, Beata Pyrżak1.
Abstract
AIM OF THE STUDY: To assess the changes in the leukocyte profile and C-reactive protein (CRP) concentration in adolescents with excess fat mass after 6-12 months of dietary intervention.Entities:
Keywords: adolescents; insulin resistance; leukocyte profile; low-grade inflammatory state
Year: 2019 PMID: 31871419 PMCID: PMC6925564 DOI: 10.5114/ceji.2019.89608
Source DB: PubMed Journal: Cent Eur J Immunol ISSN: 1426-3912 Impact factor: 2.085
Comparison of anthropometric measurements, hematological parameters, lipid profile and CRP concentration between overweight and obese children (study group) and normal weight children (control group)
| Variable | Control group ( | Study group ( |
|
|---|---|---|---|
| Height (cm) | 162.33 ±14.8 | 164.71 ±11.15 | ns |
| Body weight (kg) | 49.93 ±12.69 | 83.5 ±20.1 | < 0.001 |
| BMI (kg/m2) | 18.59 ±2.33 | 30.37 ±4.55 | < 0.001 |
| BMI SDS | –0.41 ±0.69 | 2.2 ±0.46 | < 0.001 |
| WC (cm) | 65.0 (60.0-67.0) | 91.0 (82.0-95.0) | < 0.001 |
| HC (cm) | 87.0 (75.0-89.0) | 105.0 (98.0-112.5) | < 0.001 |
| WHR | 0.77 ±0.05 | 0.85 ±0.05 | < 0.001 |
| WHtR | 0.4 (0.38-0.42) | 0.54 (0.51-0.58) | < 0.001 |
| % BFM | 22.2 (16.7-27.6) | 35.65 (32.4-41.1) | < 0.001 |
| WBC (cells × 103/μl) | 6.07 (5.21-6.9) | 6.9 (5.68-8.24) | 0.021 |
| Neutrophil (cells × 103/μl) | 3.0 (2.24-3.67) | 3.5 (2.64-4.3) | 0.020 |
| Monocyte (cells × 103/μl) | 0.48 (0.4-0.56) | 0.54 (0.5-0.61) | 0.015 |
| Eosinophil (cells × 103/μl) | 0.2 (0.12-0.33) | 0.2 (0.1-0.3) | ns |
| Basophil (cells × 103/μl) | 0.03 (0.0-0.04) | 0.01 (0.0-0.04) | ns |
| Lymphocyte (cells × 103/μl) | 2.23 (1.77-2.71) | 2.5 (2.14-2.9) | 0.075 |
| Platelet (cells × 103/μl) | 253.63 ±50.18 | 268.42 ±55.19 | NS |
| RBC (cells × 106/μl) | 4.7 (4.41-5.18) | 5.01 (4.73-5.2) | 0.013 |
| Hb (g/dl) | 13.6 (13.2-14.2) | 13.8 (13.2-14.5) | ns |
| CRP (mg/dl) | 0.5 (0.5-0.5) | 0.5 (0.5-0.8) | < 0.001 |
| Fasting glucose (mg/dl) | 84.0 ±7.55 | 83.65 ±8.96 | ns |
| TC (mg/dl) | 156.79 ±22.47 | 166.02 ±29.12 | ns |
| HDL-C (mg/dl) | 58.0 (49.0-66.0) | 43.0 (38.0-48.0) | < 0.001 |
| LDL-C (mg/dl) | 77.95 ±22.36 | 95.18 ±26.36 | 0.006 |
| TG (mg/dl) | 65.0 (54.5-87.5) | 116.0 (86.0-161.0) | < 0.001 |
Data are presented as mean ±standard deviation (SD) or median values with interquartile range as appropriate; BMI – body mass index, BMI SDS – body mass index standard deviation score, WC – waist circumference, HC – hip circumference, WHR – waist-to-hip ratio, WHtR – waist-to-height ratio, % BFM – % of body fat mass, WBC – white blood cells, RBC – red blood cells, Hb – hemoglobin, CRP – C-reactive protein, TC – total cholesterol, HDL-C – high-density lipoprotein cholesterol, LDL-C – low-density lipoprotein cholesterol, TG – triglycerides, ns – non-significant.
Correlations between white blood cells, neutrophil count, CRP concentration and selected anthropometric and biochemical parameters in overweight and obese children at the baseline visit
| Variables | WBC (cells × 103/μl) | Neutrophils (cells × 103/μl) | CRP (mg/dl) |
|---|---|---|---|
| Body weight (kg) | ns | 0.287 | 0.294 |
| WC (cm) | ns | 0.259 | 0.460 |
| HC (cm) | ns | 0.313 | 0.335 |
| % BFM | ns | 0.287 | 0.329 |
| BMI | ns | 0.307 | 0.363 |
| BMI SDS | 0.210 | 0.325 | 0.362 |
| WHtR | ns | ns | 0.343 |
| Fasting insulin (μIU/ml) | 0.216 | 0.203 | ns |
| HOMA-IR | 0.214 | 0.206 | ns |
| TG (mg/dl) | 0.269 | 0.197 | ns |
| HDL-C (mg/dl) | –0.210 | –0.250 | ns |
| TG/HDL-C | 0.295 | 0.248 | ns |
| CRP (mg/dl) | 0.235 | 0.245 | – |
Data are presented as rs – Spearman correlation coefficient and below p-value or ns – non- significant; BMI – body mass index, WC – waist circumference, HC – hip circumference, WHtR – waist- to-height ratio, % BFM – % of body fat mass, WBC – white blood cells, CRP – C-reactive protein, TG – triglycerides, HDL-C – high-density lipoprotein cholesterol, TG/HDL-C – triglycerides to high-density lipoprotein cholesterol ratio, HOMA-IR – homeostasis model assessment – insulin resistance
Fig. 1Correlations between the white blood cell count and BMI SDS in overweight and obese children at baseline
Changes in anthropometric measurements, hematological parameters, CRP concentration, lipid profile and HOMA-IR in overweight and obese children according to changes in BMI SDS at the follow-up visit
| Variable | Overweight and obese group – baseline visit ( | Overweight and obese children – the follow-up visit ( | |||||
|---|---|---|---|---|---|---|---|
| Lost weight ( | Gain weight ( | Body weight unchanged ( | |||||
| baseline visit | follow-up visit | baseline visit | follow-up visit | baseline visit | follow-up visit | ||
| Height (cm) | 164.71 ±11.15 | 163.84 ±12.15 | 165.89 ±11.44 | 164.09 ±8.06 | 166.59 ±7.84 | 164.22 ±14.34 | 167.04 ±13.35 |
| Body weight (kg) | 83.50 ±20.10 | 82.34 ±19.12 | 79.42 ±18.48 | 81.62 ±14.98 | 88.40 ±13.31 | 83.87 ±28.47 | 86.46 ±26.44 |
| BMI (kg/m2) | 30.37 ±4.55 | 30.27 ±4.04 | 28.47 ±4.11 | 30.22 ±4.74 | 31.86 ±4.64 | 30.28 ±5.52 | 30.28 ±4.86 |
| BMI SDS | 2.24 ±0.46 | 2.27 ±0.44 | 1.93 ±0.54 | 2.24 ±0.46 | 2.40 ±0.48 | 2.14 ±0.50 | 2.13 ±0.49 |
| WC (cm) | 91.0 (82.0-95.0) | 91.0 (83.0-94.0) | 86.0 (77.0-94.0) | 88.0 (82.0-94.0) | 92.0 (87.0-97.0) | 90.0 (79.0-101.0) | 89.50 (81.0-99.0) |
| HC (cm) | 105.0 (98.0-112.5) | 106.0 (90.0-111.0) | 103.0 (93.0-110.0) | 104.0 (99.0-114.0) | 110.0 (100.0-118.0) | 103.0 (95.0-112.5) | 104.0 (97.0-115.0) |
| WHR | 0.85 ±0.05 | 0.85 ±0.05 | 0.83 ±0.05 | 0.84 ±0.05 | 0.83 ±0.05 | 0.87±0.05 | 0.86 ±0.05 |
| WHtR | 0.54 (0.51-0.58) | 0.53 (0.51-0.57) | 0.51 (0.48-0.59) | 0.54 (0.49-0.58) | 0.54 (0.50-0.60) | 0.55 (0.51-0.59) | 0.54 (0.50-0.60) |
| % BFM | 35.65 (32.40-41.10) | 37.40 (33.70-40.30) | 33.20 (29.90-35.90) | 35.40 (35.00-39.70) | 36.70 (32.10-40.30) | 34.30 (31.00-40.00) | 34.30 (29.40-37.00) |
| WBC (cells × 103/μl) | 6.90 (5.68-8.24) | 6.90 (6.10-8.58) | 6.20 (5.70-7.49) | 6.50 (5.61-7.50) | 6.95 (5.95-8.15) | 7.70 (5.26-8.74) | 6.99 (4.93-8.36) |
| Neutrophils (cells × 103/μl) | 3.50 (2.64-4.30) | 3.70 (3.02-5.00) | 3.36 (2.70-3.74) | 3.15 (2.50-4.00) | 3.30 (2.56-4.32) | 3.50 (2.20-4.83) | 3.33 (2.14-4.70) |
| Monocytes (cells × 103/μl) | 0.54 (0.50-0.61) | 0.51 (0.50-0.65) | 0.47 (0.40-0.60) | 0.53 (0.40-0.66) | 0.57 (0.48-0.69) | 0.55 (0.50-0.77) | 0.58 (0.48-0.75) |
| Eosinophils (cells × 103/μl) | 0.20 (0.10-0.30) | 0.14 (0.10-0.30) | 0.20 (0.10-0.25) | 0.14 (0.10-0.26) | 0.18 (0.11-0.25) | 0.26 (0.10-0.36) | 0.17 (0.10-0.35) |
| Basophils (cells × 103/μl) | 0.01 (0.00-0.04) | 0.01 (0.00-0.07) | 0.01 (0.00-0.03) | 0.01 (0.00-0.03) | 0.02 (0.00-0.03) | 0.02 (0.00-0.04) | 0.01 (0.00-0.02) |
| Lymphocytes (cells × 103/μl) | 2.50 (2.14-2.90) | 2.40 (2.10-2.71) | 2.20 (1.90-2.59) | 2.45 (2.00-2.90) | 2.50 (2.10-3.17) | 2.80 (2.30-3.14) | 2.60 (2.13-2.92) |
| Platelets (cells × 103/μl) | 268.42 ±55.19 | 262.62 ±51.41 | 259.12 ±51.57 | 264.22 ±62.83 | 266.45 ±69.24 | 279.33 ±48.0 | 259.13 ±55.3 |
| RBC(cells × 106/μl) | 5.01 (4.73-5.20) | 5.03 (4.80-5.23) | 4.86 (4.67-5.19) | 4.96 (4.71-5.17) | 4.97 (4.70-5.12) | 5.08 (4.74-5.26) | 4.99 (4.68-5.30) |
| Hb (g/dl) | 13.80 (13.20-14.50) | 13.80 (13.20-14.40) | 13.70 (13.00-14.30) | 13.45 (12.60-14.10) | 13.55 (12.95-14.35) | 14.20 (0.50-0.75) | 14.0 (13.30-15.20) |
| CRP (mg/dl) | 0.5 (0.5-0.8) | 0.6 (0.5-0.9) | 0.5 (0.5-0.6) | 0.5 (0.5-0.6) | 0.5 (0.5- 0,6) | 0.5 (0.5-0.7) | 0.5 (0.5-0.5) |
| Fasting glucose (mg/dl) | 83.65 ±8.96 | 84.25 ±10.45 | 85.87 ±6.48 | 82.88 ±7.33 | 86.34 ±6.85 | 84.56 ±6.64 | 84.48 ±4.89 |
| Fasting insulin (μlU/ml) | 14.15 (8.56-22.10) | 15.80 (11.20-28.70) | 13.90 (9.84-23.0) | 12.0 (7.60-21.80) | 15.50 (10.90-23.90) | 13.10 (7.36-24.90) | 13.0 (11.5-21.90) |
| TC (mg/dl) | 166.02 ±29.12 | 166.09 ±31.55 | 150.78 ±24.01 | 165.75 ±28.61 | 167.77 ±31.03 | 166.78 ±22.95 | 161.0 ±24.6 |
| HDL-C (mg/dl) | 43.0 (38.0-48.0) | 43.0 (38.0-47.0) | 43.0 (39.0-46.0) | 39.1 (33.0-44.0) | 40.0 (37.0-48.0) | 44.0 (40.0-50.0) | 42.5 (40.0-48.0) |
| LDL-C (mg/dl) | 95.18 ±26.36 | 95.99 ±26.50 | 82.86 ±18.18 | 92.44 ±28.86 | 95.86 ±26.69 | 95.92 ±23.14 | 90.24 ±21.92 |
| TG (mg/dl) | 116.0 (86.0-161.0) | 118.5 (91.0-164.0) | 113.0 (74.0-144.0) | 122.0 (99.0-161.0) | 124.0 (102.0-193.0) | 98.1 (79.0-155.0) | 113.5 (90.0-143.0) |
| TG/HDL-C | 2.58 (1.91-4.06) | 2.75 (2.00-3.97) | 2.77 (1.66-3.34) | 3.78 (2.01-4.46) | 2.91 (2.00-5.12) | 2.15 (1.67-3.69) | 2.53 (2.04 -2.95) |
| HOMA-IR | 2.92 (1.79-5.24) | 3.06 (2.12-6.19) | 3.03 (2.00-4.41) | 2.48 (1.56-4.98) | 3.27 (2.52-4.98) | 2.78 (1.53-5.96) | 2.83 (2.40-4.59) |
Data are presented as mean ±standard deviation (SD) or median with interquartile range as appropriate, BMI – body mass index, WC – waist circumference, HC – hip circumference, WHR – waist-to-hip ratio, WHtR – waist-to-height ratio, % BFM – % of body fat mass, WBC – white blood cells, RBC – red blood cells, Hb – hemoglobin, TC – total cholesterol, TG – triglycerides, HDL-C – high-density lipoprotein cholesterol, LDL-C – low-density lipoprotein cholesterol, TG/HDL-C – triglycerides to high-density lipoprotein cholesterol ratio, HOMA-IR – homeostasis model assessment – insulin resistance
p < 0.001
p < 0.01
p < 0.05 (comparison between the follow-up visit vs the baseline visit)
Fig. 2Correlation between changes in the white blood cell count and changes in HOMA-IR after 6 to 12 months of dietary intervention in overweight and obese children